A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/1998
10/14/1998	CN1196056A Cycloanthelmintic inhibitors
10/14/1998	CN1196055A 2-[[2-(2-hydroxyethyl) amino] ethyl]-5-[[2-methylamino) ethyl] amino] [4,3-gh] isoquinolin-6(2H)-one as antitumor agent
10/14/1998	CN1196053A Novel heterocyclic compounds for treatment of pain and use thereof
10/14/1998	CN1196051A Pyrimidine derivatives
10/14/1998	CN1196050A Cyclic nitrones and pharmaceutical compositions containing them
10/14/1998	CN1196049A Acylated derivatives of melatonin and its analogues, useful as medicaments
10/14/1998	CN1195994A Hormone patch
10/14/1998	CN1195993A Intranasal vaccination against gastrointestinal disease
10/14/1998	CN1195992A Method and composition for enhanced parenteral nutrition
10/14/1998	CN1195991A Preparation of preventing and/or curing trichomadesis
10/14/1998	CN1195990A PGE1-containing freeze-dried preparation and process for production thereof
10/14/1998	CN1195989A Use of thienotriazolodiazepine to increase apolipoprotein A-I levels
10/14/1998	CN1195988A Immunosuppressant
10/14/1998	CN1195987A Use of carbostyril derivative for inhibiting carcinogenesis
10/14/1998	CN1195986A Paroxetine controlled release compositions
10/14/1998	CN1195985A Benzimidazole compounds
10/14/1998	CN1195984A Pharmaceutical formulations containing darifenacin
10/14/1998	CN1195983A Method of treatment for EIPH in racing stock
10/14/1998	CN1195980A Composition for topical delivery of active ingredients
10/14/1998	CN1195666A Intermediates of steroids, their preparation and uses
10/14/1998	CN1195664A New benzoxazinedione derivatives, method of producing them and use thereof
10/14/1998	CN1195662A New benzenesulfonylamine compounds, process for preparating them and pharmaceutical compositions containing them
10/14/1998	CN1195536A Plaster for curing hemiplegia, hypertension and contraception
10/14/1998	CN1195527A Low-salt medium molecular ethoxyl-starch liquid
10/14/1998	CN1195526A Citicoline compound preparation for curing optic atrophy
10/14/1998	CN1195525A Melatonin slow-releasing agent and its production process
10/14/1998	CN1195524A Pharmaceutical formulation
10/14/1998	CN1195523A 组合物 The composition
10/14/1998	CN1195522A Use of 2(3) tertiary butyl-4-hydroxy-anisole in preparation of drug for preventing and curing tissue organ traumatic disease
10/14/1998	CN1195520A Cosmetic composition in form of transparent foaming gel
10/14/1998	CN1195486A Double fibre sugar reducing powder and its preparing method
10/14/1998	CN1195469A Method for improving weight gain and feed conversion efficiency of swine
10/14/1998	CN1040213C Diaryl 5,6-fusedheterocylic acids as leukotriene antagonists
10/14/1998	CN1040212C Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions
10/14/1998	CN1040211C Matrix metalloprotease inhibitors
10/14/1998	CN1040210C Fused benzazepine derivative and pharmaceutical composition containing the same
10/14/1998	CN1040177C Medicinal preparation containing 1-N-ethyl gentamicin derivative and its preparing method
10/14/1998	CN1040176C Drug prepared by quinolone derivative for preventing and treating disturbances of intestinal mucous membrance and its use
10/13/1998	US5821371 Heterocyclic compounds and their preparation and use
10/13/1998	US5821370 Muscarinic cholinergic drugs
10/13/1998	US5821366 1,3-disubsituted-zanthines to treat diseases associated with proteins that mediate cellular activity
10/13/1998	US5821365 Compounds as enzyme inhibitors for kinases formed by reaction of amine with anhydride group to form indolmaleimide macrocycles
10/13/1998	US5821363 Antineoplastic use and pharmaceutical compositions containing them
10/13/1998	US5821331 Inhibit the proteolytic activity of proteases
10/13/1998	US5821312 Acid-functionalized saccharides as polyvalent anti-infectives
10/13/1998	US5821267 Modulating the inducible isoform over the constitutive; hypertensive, antiarthritic and diabetic agents; therapy with cytokines; toxic and septic shock
10/13/1998	US5821266 Antioxidant activity of 3-dehydroshinkimates
10/13/1998	US5821265 Inhibitors of cell-mediated disorders
10/13/1998	US5821264 Used in foodstuffs and dietary supplements to decrease lipoprotein concentration or increase feed conversion
10/13/1998	US5821261 Substituted saturated aza heterocycles as inhibitors of nitric oxide synthase
10/13/1998	US5821260 Administering compounds which block expression of vascular cell adhesion molecule
10/13/1998	US5821259 Administering histamine derivatives for inhibition of brain mast cell and neuronal secretion of serotonin, to treat migraine headaches
10/13/1998	US5821257 Thiadiazoles and their uses as antipicornaviral agents
10/13/1998	US5821256 Endothelin receptor antagonists
10/13/1998	US5821255 Branched-amino-substituted thiazoles, processes for their preparation and the pharmaceutical compositions which contain them
10/13/1998	US5821254 Uses of 9-cis-retinoic acids and derivatives thereof alone or in combination with antineoplastic agents in the prevention or treatment of cancer
10/13/1998	US5821253 Tetrahydrobenzo a!fluorene compounds and methods of use
10/13/1998	US5821252 Method of blocking nerve conduction by treatment with branched-chain esters of 2- 4-(2-piperidine-ethoxy)-benzoyl!-benzoic acid and pharmaceutically acceptable salts thereof
10/13/1998	US5821250 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
10/13/1998	US5821248 Substance p antagonists
10/13/1998	US5821246 Aniline derivatives
10/13/1998	US5821245 Use of naphthalene derivatives in treating lung carcinoma
10/13/1998	US5821243 Compounds compositions and methods for treating influenza
10/13/1998	US5821242 Administering benzimidazole compounds to inhibit the growth of picornoviruses
10/13/1998	US5821240 Pyrimido 5,4!-dipyrimidines, pharmaceuticals containing them, their use and processes for the preparation thereof
10/13/1998	US5821239 Substituted-4-amino-3-pyridinols
10/13/1998	US5821237 Active materials contain at least one cyclic polyanionic polyol, at least one sulfydryl compound and at least one zwitterionic surfactant
10/13/1998	US5821236 Tumor treatment with arabinofuranosyl purine derivatives
10/13/1998	US5821234 Administering an effective dosage of at least one antisense sequence to at least one gene expressing a cyclin or a cyclin dependent kinase which inhibits the expression of the gene
10/13/1998	US5821232 Administering renin inhibitor and angiotensin ii antagonist to treat hypertension or congestive heart failure
10/13/1998	US5821222 Cyclic depsipeptides having 18 ring atoms for combating endoparasites
10/13/1998	US5821071 By introducing a nucleotide sequence encoding a syk gene; gene expression; phosphorylation of fc-gamma receptors; for combatting infections
10/13/1998	US5821056 Polynucleotide; expression vector; binding of antibody to a growth differentiation factor-9 polypeptide indicates the presence of an oocyte
10/13/1998	US5821046 RNA oligonucleotides that bind HIV tat protein
10/13/1998	US5820883 Administering two separately microencapsulated active agents; first agent causes primary immune response, second agent is released in pulsating manner to potentiate response
10/13/1998	US5820878 Percutaneously absorbable patch
10/13/1998	US5820863 A non-naturally occuring non-rodent zona pellucida polypeptide which is the expression product of dna encoding a mammalian zona pellucia polypeptide having immunological cross-reactivity with zona pellucida protein encoded by dna
10/13/1998	US5820847 Administering a diagnostic agent complexed with a targeting ligand of folates or receptor-binding derivatives; for transporting exogenous molecules into cells with folate receptors; drug delivery
10/13/1998	US5820587 Method and kit for preventing erectile dysfunction
10/13/1998	US5820583 Surgical irrigation solution and method for inhibition of pain and inflammation
10/13/1998	US5819748 Grafting an uncompressed lyophilised crosslinked collagen into infected bone cavity with taurolidine and taurultam as antibiotics
10/13/1998	CA2132578C Method of tumor treatment
10/13/1998	CA1340084C Esters of 9-(2-hydroxyethoxymethyl)guanine having antiviral properties
10/10/1998	CA2234342A1 Pancreatitis remedy
10/08/1998	WO1998044134A2 Bacterial plasmids
10/08/1998	WO1998044119A1 NUCLEIC ACID FRAGMENTS AND POLYPEPTIDE FRAGMENTS DERIVED FROM $i(M. TUBERCULOSIS)
10/08/1998	WO1998044103A2 Protein for inhibiting apoptosis
10/08/1998	WO1998044101A1 Antisense oligonucleotides for mitogen-activated protein kinases as therapy for breast cancer
10/08/1998	WO1998044021A1 Biodegradable terephthalate polyester-poly(phosphate) polymers, compositions, articles, and methods for making and using the same
10/08/1998	WO1998043990A1 Gallic acid ester derivatives and drugs containing the same as the active ingredient
10/08/1998	WO1998043982A1 Tetracyclical derivatives from pyrimidine
10/08/1998	WO1998043981A1 Antibacterial substituted 7-acylamino-3-(methylhydrazono)methyl -cephalosporins and intermediates
10/08/1998	WO1998043978A1 Morphinane derivatives and medicinal use thereof
10/08/1998	WO1998043975A1 Pyrolopyrrolone derivatives
10/08/1998	WO1998043974A1 Pyrimidopyrimidine compounds
10/08/1998	WO1998043972A1 Pyrimidinone-1,3-oxathiolane derivatives with antiviral activity
10/08/1998	WO1998043971A1 Novel pyridine derivatives and pharmaceutical compositions containing them
10/08/1998	WO1998043970A1 Azole compounds, their production and their use
10/08/1998	WO1998043969A1 Indazoles of cyclic ureas useful as hiv protease inhibitors
10/08/1998	WO1998043968A1 Novel pyrimidine derivatives and processes for the preparation thereof

1 ... 6596 6597 6598 6599 6600 6601 6602 6603 6604 6605 6606 6607 6608 6609 6610 6611 6612 6613 6614 6615 6616 ... 7860